Issue link: http://deals.uberflip.com/i/1433150
Strategic, Operational, Research, and Technology Consulting Firm Located in Southern US #60138 Sign NDA ► 2020 Revenue Est. $5,000,000 2020 EBITDA Est. $950,000 DISCLAIMER: All information contained in this document has been provided by the subject company to Generational Equity and while believed to be correct has not been verified. Accordingly, Generational Equity makes no representations or warranties as to the accuracy and truthfulness of such information. The recipient hereof acknowledges that Generational Equity shall not be liable for any loss or injury suffered by said recipient in any way connected to the delivery by Generational Equity of this document. At all times Generational Equity and its affiliate network members is an agent for the seller and not for the buyer. Generational Equity's fees are paid by the seller. Celeste Garner Senior M&A Advisor Email: cgarner@generational.com Office: 469-892-8103 Generational Group 3400 N. Central Expressway, Ste. 100 Richardson, TX 75080 Fax: 972-392-8564 BUSINESS HIGHLIGHTS The Company specializes in strategic, operational, research, and technology consulting services with a focus on business process improvement and customer centric mission support to the commercial sector, federal and state government, and local communities. The Company's target customer base is the Federal Government, and specifically the healthcare support services of the Department of Defense, Defense Health Agency, and the Department of Health and Human Services INVESTMENT BANK OF THE YEAR 2016 - 2017 - 2018 COMPANY STATS Over 20 yrs of operations Highly profitably 25 Full-Time employees INVESTMENT APPEAL • Strong Client Relationships - The Company has several longstanding and repeat customers. The top three customers as a percentage of revenue in 2019 have been doing business with the Company an average of over 10 years each, with one dating back to 2003. • Strong Historical Sales and Earnings Growth - Revenue grew at a 9.1% CAGR between 2017 and 2019. Earnings as measured by EBITDA grew at a 45.2% CAGR between 2017 and 2019. • COVID-Resistance - Through the first nine months ended September 30, 2020, revenue reached over $3,900,000, with very high profitability. This solidifies the Company's very conservative year- end base year revenue of $5.0 million, and EBITDA of $950,000. • Favorable Outlook for Industry Growth - Revenue for US consulting services is forecast to grow at an annual compounded rate of 6% between 2020 and 2024. GROWTH OPPORTUNITY Healthcare Research Grant Writing Healthcare Administrative Support Services Revenue Mix